People may know chemotherapy as a cancer treatment more readily than immunotherapy. But immunotherapy is gaining traction, and for good reason.
Immunotherapy is a promising advancement in the treatment of many cancers, including bladder cancer. It has even become the first line of treatment for some cancers.1
Bladder cancer has a long track record with immunotherapy. One of the first immunotherapies approved by the U.S. Food and Drug Administration was for bladder cancer, in 1990.2,3
